201 related articles for article (PubMed ID: 15213471)
1. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
[TBL] [Abstract][Full Text] [Related]
2. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
[TBL] [Abstract][Full Text] [Related]
3. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
Lam K; Zhang DE
Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
[TBL] [Abstract][Full Text] [Related]
5. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
Growney JD; Shigematsu H; Li Z; Lee BH; Adelsperger J; Rowan R; Curley DP; Kutok JL; Akashi K; Williams IR; Speck NA; Gilliland DG
Blood; 2005 Jul; 106(2):494-504. PubMed ID: 15784726
[TBL] [Abstract][Full Text] [Related]
6. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
7. Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression.
Lorsbach RB; Moore J; Ang SO; Sun W; Lenny N; Downing JR
Blood; 2004 Apr; 103(7):2522-9. PubMed ID: 14630789
[TBL] [Abstract][Full Text] [Related]
8. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
9. RUNX1/AML1: a central player in hematopoiesis.
Okuda T; Nishimura M; Nakao M; Fujita Y
Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959
[TBL] [Abstract][Full Text] [Related]
10. Runx1/AML1 in normal and abnormal hematopoiesis.
Yamagata T; Maki K; Mitani K
Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
Bluteau D; Gilles L; Hilpert M; Antony-Debré I; James C; Debili N; Camara-Clayette V; Wagner-Ballon O; Cordette-Lagarde V; Robert T; Ripoche H; Gonin P; Swierczek S; Prchal J; Vainchenker W; Favier R; Raslova H
Blood; 2011 Dec; 118(24):6310-20. PubMed ID: 21725049
[TBL] [Abstract][Full Text] [Related]
12. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
13. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.
Ross K; Sedello AK; Todd GP; Paszkowski-Rogacz M; Bird AW; Ding L; Grinenko T; Behrens K; Hubner N; Mann M; Waskow C; Stocking C; Buchholz F
Blood; 2012 May; 119(18):4152-61. PubMed ID: 22411870
[TBL] [Abstract][Full Text] [Related]
14. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
Ganly P; Walker LC; Morris CM
Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
16. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
17. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
[TBL] [Abstract][Full Text] [Related]
18. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region.
Goyama S; Yamaguchi Y; Imai Y; Kawazu M; Nakagawa M; Asai T; Kumano K; Mitani K; Ogawa S; Chiba S; Kurokawa M; Hirai H
Blood; 2004 Dec; 104(12):3558-64. PubMed ID: 15271791
[TBL] [Abstract][Full Text] [Related]
19. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.
Asou N
Crit Rev Oncol Hematol; 2003 Feb; 45(2):129-50. PubMed ID: 12604126
[TBL] [Abstract][Full Text] [Related]
20. Pathways in blood and vessel development revealed through zebrafish genetics.
Crosier PS; Kalev-Zylinska ML; Hall CJ; Flores MV; Horsfield JA; Crosier KE
Int J Dev Biol; 2002; 46(4):493-502. PubMed ID: 12141436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
